Ready to cut time to save lives? Request consultation
Future-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
“A huge advantage”
Listen to Ehsan Ghaderi, Head of Department, and Sofia Persson, Consultant Physician, Bacteriology Uppsala University Hospital, talks about how ASTar have helped save time in the lab.
“You will be much faster in adjusting the treatment”
Listen to Martin Sundqvist, Senior consultant, PhD, Clinical Microbiology, Örebro University Hospital. President of the Swedish Society of Clinical Microbiology speak about the value of rapid AST, true MIC values and more.
Find more words about us here
News & events
Q-linea publishes digital annual report for 2021
Q-linea submits US market application to FDA
Q-linea achieves CE-mark conformity to IVDR for the ASTar instrument
Q-linea AB (publ) (OMX: QLINEA) today announces that the company has achieved In Vitro Diagnostics Regulation (IVDR) status for…
Read more >
Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.Q-linea as an investment
Q-linea is an innovative infection diagnostics company whose ambition is to offer products that benefit patients, healthcare providers and society.
Get in touch
We are happy to help. Please contact us with any questions or queries, we are just a click away.